N. McGuire

Sympathetic nervous system function as measured by I-123 metaiodobenzylguanidine predicts transplant-free survival in heart failure patients with idiopathic dilated cardiomyopathy.

L. Wagoner, M. Gerson, N. McGuire, 2003, Journal of cardiac failure.

Activity of the uptake-1 norepinephrine transporter as measured by I-123 MIBG in heart failure patients with a loss-of-function polymorphism of the presynaptic α2C-adrenergic receptor

S. Liggett, L. Wagoner, M. Gerson, 2003, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

Infections in the heart transplant recipient.

L. Baas, L. Wagoner, N. McGuire, 2003, Critical care nursing clinics of North America.

Polymorphisms of the b 2 -Adrenergic Receptor Determine Exercise Capacity in Patients With Heart Failure

G. Dorn, S. Liggett, W. Abraham, 2000 .

Polymorphisms of theb2-Adrenergic Receptor Determine Exercise Capacity in Patients With Heart Failure

G. Dorn, S. Liggett, W. Abraham, 2000 .

Polymorphisms of the beta1-adrenergic receptor predict exercise capacity in heart failure.

G. Dorn, S. Liggett, L. Wagoner, 2002, American heart journal.

Polymorphisms of the β2-Adrenergic Receptor Determine Exercise Capacity in Patients With Heart Failure

G. Dorn, S. Liggett, W. Abraham, 2000 .

Polymorphisms of the beta(2)-adrenergic receptor determine exercise capacity in patients with heart failure.

G. Dorn, S. Liggett, W. Abraham, 2000, Circulation research.

A functional polymorphism of the Galphaq (GNAQ) gene is associated with accelerated mortality in African-American heart failure.

S. Kardia, G. Dorn, R. Kelly, 2007, Human molecular genetics.

Carvedilol improves left ventricular function in heart failure patients with idiopathic dilated cardiomyopathy and a wide range of sympathetic nervous system function as measured by iodine 123 metaiodobenzylguanidine

W. Abraham, L. Wagoner, M. Gerson, 2002, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

Abstract 2001: Genetic {beta}-Blockade: A G-Protein Coupled Receptor Kinase-5 Polymorphism That Inhibits Beta-Adrenergic Receptor Signaling is Protective in Heart Failure

S. Kardia, G. Dorn, R. Kelly, 2006 .